THORN RUN PARTNERS

Lobbying for BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. · pharmaceutical company

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Connecticut · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 1

Health Issues

Policies related to creating incentives for innovation in the life sciences.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.